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Abstract: The risk of different oral problems (root caries, tooth mobility, and tooth loss) can be
increased by the presence of periodontal disease, which has also been associated with a growing list of
systemic diseases. The presence of some bacteria is the primary etiology of this disease; a susceptible
host is also necessary for disease initiation. In this respect, the progression of periodontal disease
and healing of the periodontal tissues can be modulated by nutritional status. To clarify the role of
lipids in the establishment, progression, and/or treatment of this pathology, a systematic review
was conducted of English-written literature in PubMed until May 2016, which included research
on the relationship of these dietary components with the onset and progression of periodontal
disease. According to publication type, randomized-controlled trials, cohort, case-control and
cross-sectional studies were included. Among all the analyzed components, those that have any
effect on oxidative stress and/or inflammation seem to be the most interesting according to current
evidence. On one hand, there is quite a lot of information in favor of a positive role of n-3 fatty acids,
due to their antioxidant and immunomodulatory effects. On the other hand, saturated fat-rich diets
increase oxidative stress as well the as intensity and duration of inflammatory processes, so they
must be avoided.
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1. Introduction
Periodontal disease is a multifactorial pathology featured by the breakdown of periodontal
tissues [1]. There is an increasing proportion (from 30% to 65% over the last decades) of adults
retaining their teeth until late in life [2], and, nowadays, periodontal disease is a serious problem in
older adults [3]. Additionally, the risk of other oral problems (root caries, tooth mobility, and tooth
loss) can be increased by the presence of periodontal disease, which has also been associated with
a growing list of chronic systemic diseases and impaired cognition [4–16].
Traditionally, research on the effect of nutrition on oral disease has focused on the dietary effects
on the risk of caries [17]. However, it is less understood how the diet affects the development and
progression of periodontal disease. A bidirectional correlation has been reported among nutrition,
dietary intake, and oral health [18,19]. On one hand, some studies have indicated that oral health
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status may have implications for dietary intake [20–22]. On the other hand, it is largely assumed that
the progression of periodontal disease and healing of the periodontal tissues can be modulated by
nutritional status. Actually, in spite of the fact that the presence of bacteria is the primary etiology
of this disease, a susceptible host is also necessary for disease initiation [23]. Furthermore, many
inflammatory conditions and/or diseases, such as type 2 diabetes mellitus (DM), cardiovascular
diseases, and rheumatoid arthritis have been related to diet, all of which have been associated with
periodontitis [24]. Likewise, nutritional status could affect the integrity of both hard and soft tissues
in the oral cavity [23]. First, during teeth development, foods provide a nutritional or systemic effect
that may affect the maturation of dentine and enamel. Then, when the teeth have erupted, foods can
influence the maintenance of their structure through dietary and topical effects [25]. Regarding all of
these implications, it has been hypothesized that “periodontal treatment could be enhanced with the
addition of certain nutrients to periodontal therapy, providing a safe method to potentiate the clinical
response following treatment” [26]. In particular, it has been observed that the lipid composition of
the cell membranes and blood lipoprotein content can be modified through the diet [27–29], which has
been linked to susceptibility to oxidative damage [30]. Likewise, the response against certain bacterial
products can also be modulated by membrane lipid profile [31]. For these reasons, some modifications
of dietary patterns affecting lipid profiles could be interesting to both preventing periodontal diseases
and improving periodontal health, since all components affected by them are considered key aspects
in the pathogenesis of periodontal disease [11].
There are some reviews which provide information about the association between periodontitis
and diet components [3,24,25,32–39] although many of them were restricted to certain population
groups [3], study types [3,24,34], and/or did not include lipids [3,24,26,35]. However, few attempts
of systematic reviews have been carried out [1,3,24,34]. Overall, the systematic approach with the
focused question is precluded by a paucity of nutritional interventions and a wide heterogeneity of
designs. This paper systemically reviews the literature available on databases until May 2016 on
the relationship of lipids with the development and progression of periodontal disease in humans,
attending with special interest to dietary interventions and implications of each one for mechanisms
involved in theses pathologies.
2. Results
A total of 5564 publications were detected in the initial search. After applying inclusion and
exclusion criteria, title and abstract screening left 220 available articles. After full-text reading,
13 studies were selected, with one that was duplicated and eliminated (Figure 1).
The relationship between dietary lipids and periodontal disease has been addressed by many reports.
These included both observational (Table 1) and experimental (Table 2) studies. Observational studies
were represented by two cross-sectional [40,41], a case-control [42], and three cohort studies [43–45].
Among the selected cross-sectional studies, dietary fat intake was estimated in two studies [40,41].
In one of them, total dietary intake of carbohydrates, along with many other nutrients, was assessed
by a food frequency questionnaire (FFQ) in adults from Japan using associated data from the 2005
National Health and Nutrition Examination Survey (NHANES). After excluding pregnant women and
subjects younger than 20 years, the remaining individuals (n = 3043) were divided into two groups
according to their individual maximum Community Periodontal Index (CPI) values (0–2 or 3–4) to
subsequent analyses. Only total dietary fat intake, in terms of total amount and percentage of energy,
was available, reporting that fat intake was lower in the group with higher Community Periodontal
Index (CPI) (50.8 ˘ 21 vs. 55.3 ˘ 23.1 g and 23.2% ˘ 7% vs. 25.2% ˘ 7.3% Kcal, p < 0.001). After
adjusting for confounders in the multivariate logistic regression analysis, only fat as percentage of
calories was inversely associated with advanced periodontal disease (adjusted odds ratio (OR) = 0.984,
p = 0.026) [40]. The other available study was performed using a subset of 9182 adult participants
in the U.S. NHANES. This study showed a negative association of dietary intake of representative
polyunsaturated fatty acids (PUFA) belonging to n-3 series with moderate to severe periodontitis.
Int. J. Mol. Sci. 2016, 17, 1202 3 of 13
The adjusted ORs of periodontitis associated with the lowest tertile of n-3 PUFA intake compared with
the highest were 0.78 (95% confidence interval (CI): 0.61–1.00, p = 0.009) for docosahexaenoic acid
(DHA), 0.85 (95% CI: 0.67–1.08, p = 0.10) for eicosapetanoic acid (EPA), and 0.86 (95% CI: 0.60–1.23,
p = 0.28) for γ-linoleic acid (GLA). These associations were changed in a low-way by multivariate
adjustment, as well as after DHA, EPA, or GLA dietary supplements users’ exclusion [41].
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(2.04% ± 0.17% vs. 2.54% ± 0.41% mole; p = 0.01) [42]. 
All the cohort studies reviewed were based on a subset from the Niigata City (Japan) study. 
EPA and DHA intakes effect on periodontal disease events over 5 years were evaluated in one of 
these studies, but only DHA led to relevant results. Individuals who consumed the lowest intake (1st 
tertile) of DHA presented an incidence rate ratio (IRR) of 1.49 (95% CI: 1.01–2.21) with respect to the 
highest tertile after simultaneous adjustment for possible confounders [43]. In another study, dietary 
n-6 to n-3 PUFA ratio was considered as the main predictor to estimate its influence on periodontal 
disease events after 3 years of follow-up. A high dietary n-6 to n-3 PUFA ratio was significantly 
associated with a greater number of periodontal disease events in Poisson regression analysis [44].  
In the last cohort study, saturated fatty acids (SFA) intake was evaluated with respect to the same 
outcome. Among non-smokers, it was found that high dietary intake of SFA was associated with 
more periodontal disease events. In more detail, the multivariate adjusted relative risk (RR) values 
were 1.00, 1.19 (95% CI: 0.72–1.97), 1.55 (95% CI: 0.95–2.52), and 1.92 (95% CI: 1.19–3.11), in the 1st, 
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Table 1. Observational studies on lipids association with periodontal disease.
Reference; Study Type Subjects; Age Main Outcomes/Groups Compared Exposures Main Results/Conclusion
Hamasaki, et al., 2016 [40]; CS 3043 NHANES participants(Japan) ě20 years Adjusted OR of CPI = 3–4 Dietary intake of total fat (wt and %E)
Negative association with dietary
intake of fat in %E
Naqvi, et al., 2010 [41]; CS 9182 NHANES 1999–2004participants (USA); ě20 years Adjusted OR of periodontitis
1 Dietary intake of FA Negative association with n-3 PUFA,DHA, EPA and GLA
Requirand, et al., 2000 [42]; CC 105 patients (France)41.1 ˘ 2.6 years/43.4 ˘ 6.6 years
Suffered from bone loss ď3 mm on several
teeth vs. normal bone height-periodontium Serum levels of PUFA
n-6 PUFA were higher in patients
with bone loss, whereas n-3 PUFA
were lower
Iwasaki, et al., 2010 [43]; C 55 Niigata study participants(Japan); 74 years IRR of periodontal disease events
2 Dietary intakes of DHA, and EPA Negative association withDHA intake
Iwasaki, et al., 2011 [44]; C 235 Niigata study participants(Japan); 75 years Adjusted RR of periodontal disease events
3 Dietary intakes energy- adjusted of n-6
and n-3 PUFA and n-6/n-3 PUFA ratio
Positive association with n-6/n-3
PUFA ratio
Iwasaki, et al., 2011 [45]; C 264 Niigata study participants(Japan); 75 years Adjusted RR of periodontal disease events
3 Energy-adjusted dietary intakes of SFA Positive association
1 PPD ě 4 mm and AL ě 3 mm in any mid-facial or mesial tooth; 2 CAL ě 6 mm in ě2 teeth and PPD ě 5 mm in ě1 site; 3 number of teeth with AL ě 3 mm/year. Abbreviations:
%E: percentage of Energy; AL: attachment loss; C: cohort study; CC: case-control; CPI: Community Periodontal Index; CS: cross-sectional study; DHA: docosahexaenoic acid;
EPA: eicosapentanoic acid; FA: fatty acid; GLA: γ-linoleic acid; IRR: incidence rate ration; NHANES: National Health and Nutrition Survey; OR: Odds ratio; PUFA: polyunsaturated
fatty acids; RR: relative risk; SFA: saturated fatty acids; wt: weight; y: years; PPD: periodontal probing depth; CAL: clinical attachment loss.
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Table 2. Experimental studies on lipids effect on periodontal disease.
Reference; Study
Type Subjects; Age Experimental Treatments (Duration) Analytic Measurement Main Results/Conclusions
Campan, et al.,
1997 [46]; RCT
37 healthy volunteers with
intensive oral hygiene for 14 days
Oral hygiene abstention (29 days), in
combination with supplementation with
fish oil or olive oil as placebo (last 8 days)
PI, GI, PBI, and gingival levels (only
in 10 volunteers) of AA, EPA, DHA,
DPA, PGE2 and LTB4
Fish oil supplements reduced GI,
but there are no differences
between experimental and control
group. LTB4 was lower fish oil
treated subjects
Rosenstein, et al.,
2003 [47]; RCT (DB)
30 subjects with periodontitis;
18–60 years
Supplementation with EPA or borage oil,
both, or a mixture of olive and corn oil as
placebo (12 weeks)
PI, MGI, BOP, PPD and CAL and
salivary RANKL and MMP-8
Supplementation with borage oil or
EPA improved PPD, but only
borage oil effect was significant
respect to placebo. Additionally, it
also improved MGI
Deore, et al.,
2014 [48]; RCT (DB)
60 subjects with moderate and
severe chronic periodontitis;
45.4 ˘ 4.9/44.5 ˘ 5.2 years
Supplementation with n-3 PUFA or
placebo; after SRP (6 or 12 weeks)
ABL, P. gingivalis identification,
serum FA profile
Treatment reduced PPD and
salivary RANKL and MMP-8 levels;
and increased CAL
Martinez, et al.,
2014 [49]; RCT (DB)
15 patients with generalized
chronic periodontitis
(43.1 ˘ 6/46.1 ˘ 11.6 years)
Supplementation with n-3 PUFA or
placebo; after SRP (12 months)
% BOP, visible plaque index, PPD
and CAL No effect
El-Sharkawy, et al.,
2010 [50]; RCT (DB)
80 subjects with advanced chronic
periodontitis; 30–70 years
Supplementation with fish oil and aspirin
or placebo; after SRP (3 or 6 months)
PI, GI, OHIS, BOP, SBI, PPD, CAL
and serum levels of CRP
Supplementation with borage oil or
EPA improved PPD, but only
borage oil effect was significant
respect to placebo. Additionally, it
also improved MGI
Naqvi, et al.,
2014 [51]; RCT (DB)
46 subjects with moderate
periodontitis; adults
Supplementation with DHA or soy/corn
oil capsules, in combination with aspirin
(3 months)
GI, PI, BOP, PPD, GCF levels of
hsCRP, IL-6 and IL-1β, systemic
inflammatory markers plasma
levels, and erythrocytes fatty acids
Supplementation with DHA
decreased mean PPD and GI. This
was accompanied by lower hsCRP
and IL-1β levels in GCF
Abbreviations: AA: arachidonic acid; ABL: alveolar bone loss; BOP: bleeding on probing; CAL: clinical attachment loss; CRP: C-reactive protein; d: days; DB: double-blind;
DHA: docosahexaenoic acid; EPA: eicosapentanoic acid; FA: fatty acid; GCF: gingivocrevicular fluid; GI: gingival index; hsCRP: high sensitive C-reactive protein; IL-6: interleukin-6;
IL-1β: interleukin-1β; LTB4: leukotriene B4; m: months; MGI: modified gingival index MMP-8: matrix metalloproteinase-8; OHIS: oral health index; PBI: papillary bleeding index;
PGE2: prostaglandin E2; P. gingivalis: Porphyromonas gingivalis; PI: plaque index; PPD: periodontal probing depth, PUFA: polyunsaturated fatty acids; RANKL: receptor activator of
nuclear factor κB ligand ; RCT: randomized-controlled trial; SBI: sulcus and bleeding index SRP: scaling and root planning; y: years; w: weeks.
Int. J. Mol. Sci. 2016, 17, 1202 6 of 13
Among the collected studies, six dietary interventions were found [46–50]. The earliest study was
conducted by Campan, et al. [46] on subjects without oral hygiene as a model of gingivitis, where
subjects received supplements of fish oil (n-3 PUFA-rich) or olive oil (as placebo). After a short-period
(8 days), Gingival Index (GI) was reduced by fish oil (p < 0.05), but there were no differences between
experimental and control groups. Subsequently, other investigations have been aimed at treating
patients with periodontitis. The first one [47], performed on adults with periodontitis, used refined
olive oil mixed with corn oil as placebo, and fish oil or borage oil as a source of n-3 (EPA), or n-6 (GLA)
PUFA, respectively. Different periodontal parameters were measured at baseline and after treatment
(12 weeks). The Modified Gingival Index (MGI), Plaque Index (PI), periodontal probing depth (PPD),
and β-glucuronidase levels in gingivocrevicular fluid (GCF). After treatment, subjects treated with
borage oil displayed improvement of gingival inflammation (1.04 vs. 0.68, p = 0.016). Subjects taking
either fish or borage oil alone displayed an improvement in PPD. Statistically significant differences
were found only when borage oil and placebo were compared (´0.50 vs. 0.02, p = 0.044). No change
was observed in GCF or β-glucuronidase levels. Four other interventions were done after a scaling and
root planning (SRP) treatment [48–51]. In one of these studies [48], subjects with moderate and severe
chronic periodontitis taking n-3 PUFA supplements (comprising a combination of EPA and DHA)
were compared with others taking placebo. After 12 weeks of treatment, several periodontal disease
outcomes improved, which included PPD (2.15 ˘ 0.53 vs. 2.77 ˘ 0.47 mm, p < 0.05), clinical attachment
loss (CAL) (2.73% ˘ 0.98% vs. 3.72% ˘ 0.62%, p < 0.05), GI (2.23 ˘ 0.57 vs. 1.76 ˘ 0.63, p < 0.05); and
sulcus bleeding index (SBI, 1.41 ˘ 0.30 vs. 1.80 ˘ 0.39, p < 0.05). In addition, most of them improved
after 6 weeks. These were PPD (2.61˘ 0.52 vs. 3.19˘ 0.48 mm, p < 0.05), SBI (1.65 ˘ 0.28 vs. 2.06 ˘ 0.40,
p < 0.05), and GI (1.32 ˘ 0.21 vs. 1.58 ˘ 0.33, p < 0.05). However, PI remained unchanged among
groups. Another study was carried out for a longer period of time (12 months) on generalized chronic
periodontitis patients. In this study, supplements of DHA and EPA had no effect on the percentage of
sites with bleeding on probing (BOP), visible PI, PPD, or clinical attachment loss. However, sample
size in this research (n = 15) was quite reduced [52]. In the next study, the combination of n-3 PUFA
and aspirin was tested on advanced chronic periodontitis patients. After 3 and 6 months of treatment,
a PPD reduction (´2 mm vs. ´1.4 mm at 6 months, p < 0.05) and a gain of attachment in n-3 PUFA fed
subjects with respect to both baseline and control group were confirmed by statistical analyses (75.3%
vs. 28.6% sites with 1 to 3 mm gain, 0.8% vs. 0.1% sites with more of 4 mm gain at 6 months, p < 0.05).
At 3 and 6 months, the n-3 group showed a significant reduction in salivary receptor activator of
nuclear factor κB ligand (RANKL) and matrix metalloproteinase-8 (MMP-8) levels compared with
baseline. Levels were also lower than the control group at 6 months (p < 0.01). Consumption of
supplements containing n-3 PUFA and aspirin led to a significant variation in the frequency of pockets
with PPD less than 4 mm (34.3% gain at 3 months and 39.1% at 6 months vs. ´26.9% at 3 months
and ´31.5% at 6 months, p < 0.05) [53]. In the remaining study, periodontitis patients also received
an aspirin treatment, but in this case, the treatment group was supplemented with DHA while the
control group was treated with soy and corn oil supplements. Despite possible aspirin effect, DHA
supplements decreased the mean PPD (´0.29 ˘ 0.13 mm, p = 0.03) and GI (´0.26 ˘ 0.13, p = 0.04),
although there were no differences in PI or BOP. Along with periodontal health assessment, levels
of different molecules related to inflammation were also measured in both GCF and plasma. Results
analysis showed lower levels of GCF, high sensitivity C-reactive protein (hsCRP) (´5.3 ˘ 2.4 ng/mL,
p = 0.03), and IL-1β (´20.1 ˘ 8.2 pg/mL, p = 0.02), but not IL-6 or systemic hsCRP. Moreover, in this
study, the adherence to dietary modification was confirmed by measurement of DHA level in red blood
cells (this fatty acid increased from 3.6% ˘ 0.9% to 6.2% ˘ 1.6% as a consequence of supplementation).
3. Discussion
In spite of the information collected in this review, in many cases, there was little evidence
supporting some degree of relationship between periodontal disease and lipid intake. This may
be because inferences often come from observational studies, mostly cross-sectionals. Furthermore,
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many of the reviewed studies have been performed in certain age groups, or with particular diseases
or physiological situations. So, translating these findings to the overall population is hampered.
In addition, few articles investigated the mechanisms underlying the observed relationships. Moreover,
although indices used to evaluate periodontal health are few and mostly accepted (such as Russell’s
periodontal index, CPI, or GI), there is a wide variety of periodontitis definitions based on alveolar
bone loss (ABL), PPD, CAL, or even bleeding (BOP). Consequently, comparisons among findings
from different publications are not easy. Nutritional assessment in observational studies may also be
inconvenient. When dietary intakes are estimated by 24-h [40,41] or 3-day recalls [42,43], consequent
bias may exist, namely in investigations with small sample sizes. Alternatively, conclusions in many
cases are derived only from macronutrient assessment in blood [42], but these values are not always
directly related to dietary intake. Both methodological features could help to explain why some papers
reported no associations or associations only related to certain age groups. In addition, observed
associations could be (at least in part) a consequence of an excess in energy intake or to any nutritional
deficiency that might occur when dietary intake is modified far from healthy dietary recommendations.
On one hand, experimental studies on macronutrient effects often have a difficult interpretation,
particularly those focused on the role of quantitative changes in diet. Namely, increases in lipid content
usually lead to hypercaloric diets.
Despite these difficulties, it is possible to draw some conclusions. Studies evaluating the possible
effects of total amount of fat were only represented by a single study in Japanese adults [40]. It has
been proposed that a high fat intake might lead to enhanced oxidative stress because of an overloading
of the Krebs cycle, among other reasons [38,39]. Oxidative stress has been associated with periodontal
disease exerting its effects by means of direct damage to cells. It has been related through the
activation of redox-sensitive transcription factors, leading to the production of pro-inflammatory
molecules (Figure 2) which enhance and propagate the inflammatory response, elevating the local
levels of oxidative stress [38,39]. Unexpectedly, results from the study mentioned suggested a positive
association between periodontal health and fat intake [40]. Several questions could help to explain
this rare result. On one hand, a higher percentage of fat in the diet does not necessarily imply a
higher intake of calories that can overload the Krebs cycle. On the other hand, dietary fat quality
is very important. However, both aspects were not collected by the Japanese study. In this sense,
potential effects of different fatty acid types (derived directly from the diet or as supplements) on
periodontal disease have been investigated. PUFAs, particularly n-3 PUFAs, have received the most
attention, although other fatty acid types have been also studied. Overall, studies conferred a positive
role to n-3 PUFA over periodontal health [41–44], and negative roles to SFA [45]. In turn, results
for n-6 PUFA are discussed because it is well known that some of these fatty acids have harmful
associations [42,53]. When n-6 PUFAs have been studied directly in comparison with n-3 PUFAs,
the former have always reported clearly negative effects [44]. Among studies in favor of these
associations, there are some cohort studies, all of them based on subsets from the Niigata City
(Japan) study [43,44]. In addition, some nutritional interventions on n-3 PUFA have demonstrated a
beneficial effect on periodontitis [48,50]. This was expected because of anti-inflammatory properties
have been widely attributed to n-3 PUFA, which are in fact able to down-regulate pro-inflammatory
gene expression [53] and the production of pro-resolving lipid mediators, resolvins, maresins, and
protectins [33]. Interestingly, it has also been reported that the n-3 PUFAs EPA and DHA have a
broad range of antibacterial activities, including the inhibition of putative periodontal pathogens,
including Porphyromonas gingivalis, Fusobacterium nucleatum, and Prevotella intermedia, among others [54].
The negative association between fat-rich diets and periodontitis found in the Japanese sample could
be explained by the role of these fatty acids, since the population of Japan shows a much higher
proportion of dietary n-3 PUFA [55] than is present in an average Western diet [56]. Concerning
n-6 PUFAs, it is well known that their derived pro-inflammatory prostanoids directly compete with
the anti-inflammatory n-3 PUFAs. This fact makes it easy to understand the importance of carefully
considering the n-6-to-n-3 PUFA ratio in the diet. In relation to saturated fat, the concern is that
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an excess metabolically leads to an increased production of low density lipoprotein (LDL) cholesterol.
This, when oxidized, forms oxidized LDL, which binds to toll-like receptor 4 (TLR-4) on neutrophils,
again activating downstream pro-inflammatory cascades [38], among other things.
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periodontal disease and dietary lipids in humans were included, even when they included only 
people belonging to certain age groups or subject to any special physiological condition or illness 
(pregnancy, menopause, DM, and others). For this reason, studies had to assess any periodontal 
Figure 2. Mechanisms for fat intake effects. Abbreviations: LDL: low-density lipoprotein, PUFA:
polyunsaturated fatty acids, SFA: saturated fatty acids, TLR-4: toll-like receptor-4.
It would be possible to conclu e that macronutrients that have any effect o antioxida status
or inflammatory proce ses should be consi ered for th prevention or improvement of periodontal
disease. In this sense, there is quite a body of evidence to consider regarding the positive role of
including a high proportion of n-3 PUFA in the diet. On the other hand, those lipids or diets that
increase oxidative stress or affect the immune system should be avoided to prevent periodontal disease
or to achieve better results after periodontal therapies. These would include saturated fat-rich or
hypercaloric diets. However, after analyzing all collected data, there is a need for more studies to
confirm the effects of diet, mainly cohort studies with large sample sizes. Additionally, more consensus
in period ntitis diagnosis and improvement of dietary i t ke estim ti s re needed t enhance our
overall understanding. Ind ed, problems i the last issue also focus on th importance of carrying
out mo e se sitive experi ental investigations and/or met odological approaches. In the future,
the design of new clinical trials that combine dietary interventions as periodontal therapies might
be the most useful tools to emphasize the importance of diet in these pathologies. Regardless, it
would be appropriate to maintain an optimal dietary n-6:n-3 PUFA ratio. This is consistent with the
recommendations of the 2011 European workshop on Periodontology that suggested that “the dental
team should consider including advice to all patients on increasing levels of fish oils, fibre, fruit, and
vegetables, and to reduce levels of refined sugars as part of a periodontal prevention/treatment regime
and a general health benefit message” [39,57].
4. Material and Methods
4.1. Selection Criteria
Inclusion a d exclusion criteria f r the selection f studies to review were established prior to the
start with the literature search. All relevant studies investigating the association between periodontal
disease and dietary lipids in humans were included, even when they included only people belonging to
certain age groups or subject to any special physiological condition or illness (pregnancy, menopause,
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DM, and others). For this reason, studies had to assess any periodontal health condition and dietary
intake or clear nutritional status markers for the mentioned dietary components. Regarding study
design, cross-sectional, cohort, and case-control studies were selected within those belonging to
observational type. On the other hand, only randomized-controlled trials (RCTs) were accepted from
experimental studies collected.
4.2. Information Source and Search Terms
The electronic database of the National Library of Medicine, Washington, D.C. (MEDLINE:
PubMed) was used to search potential publications for this review. Firstly, two themes were created
and combined by using the Boolean operator “AND”. In turn, the operator “OR” was used to create
each theme, combining search terms appearing as either explorer text words or Medical Subjects
Headings (Mesh), when they existed and it was not contained within other also used. Asterisk (*) also
was used after some terms to search for all terms that begin with the word. The selected periodontal
disease related terms were: periodontal, periodontitis, gingivitis and it was also included the following
outcome measurement related to periodontal disease: “alveolar bone loss” (Mesh) OR “periodontal
diseases” (Mesh) OR “periodontal attachment loss” (Mesh) OR “periodontal index” (Mesh) OR
“gingival hemorrhage” (Mesh) OR “periodontal disease” OR periodontitis OR “alveolar bone loss” OR
“alveolar bone resorption” OR “tooth attachment” OR “tooth mobility” OR “gingivitis” OR “clinical
attachment loss” OR “periodontal attachment level” OR “attachment loss” OR “periodontal pocket” OR
“pocket depth” OR “probing depth” OR “bleeding on probing” OR “gingival bleeding” OR “gingival
hemorrhage” OR “gingival index” OR “bleeding index” OR “periodontal index”. In addition to this,
a second theme related to nutrition or diet was created. Search terms were the next: “food” (Mesh) OR
“diet” (Mesh) OR “eating” (Mesh) OR “nutrition surveys” (Mesh) OR “nutrition assessment” (Mesh)
OR “nutrition therapy” (Mesh) OR “nutrition processes” (Mesh) OR “nutritional status” (Mesh) OR
nutrition* OR nutrition OR nutrient* OR nutrient OR food OR dietary OR diet* OR intake OR intakes
OR consumption* OR consumption OR ingestion OR eating.
4.3. Search Strategy
The search strategy was focused on English-written studies from inception of the database until
May 2016. A comprehensive literature search was run independently by two of the review authors.
Firstly, a screening adjusted for higher sensitivity (i.e., without restrictive search items) of title and
abstract was carried out. Reviews that could mention studies related to the established selection criteria
were collected, and a screening was done to find new additional articles that would follow the rest of
the process; Secondly, full-texts were obtained and after full-text screening; those articles that did not
accomplish the proposed selection criteria were excluded. Duplicated studies were removed; Moreover,
full-text was screened in the web for articles whose title suggested that they were related to these
review objectives; Finally, when there were disagreements or inconsistencies relative to the inclusion
of some publications or data, all authors discussed the issue to eventually achieve mutual consensus.
4.4. Data Collection Process, Data Items, and Summary Measures
Specific data about populations, interventions, study designs, as well as outcomes relevant for
this review’s questions were extracted from articles. Data from eligible studies were independently
evaluated. When they were available, mean, mean differences and standard deviations of outcome
measurements (like clinical outcomes for periodontal disease, nutritional status, or dietary intakes),
were included in our description of the results. In the same sense, association measurements were
also collected, such as correlation or regression coefficients, IRRs, ORs, RRs and their corresponding
95% CI, as well as significance levels considered or p-values, but only if significant associations and/or
differences were found.
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4.5. Quality Assessment and Risk of Bias
Subsequently, potentially-relevant publications were read in full to determine their quality, mainly
through the risk of bias assessment. Several criteria depending on the study design were applied to
determine methodological quality of each publication. In the case of observational studies, evaluation
and strategies to deal with them were considered in addition to risk of bias. According to the
prevention of confounding effects, the employment of randomization, only in clinical trials, matching,
or restriction, were explored at the design level, while the use of multivariate analysis, stratification, or
frequency matching was appraised at the data analysis level. As to the risk of bias, it four types of
bias have been proposed: selection, detection, attrition, and reporting bias [58]. Other authors have
simplified this classification into two categories: selection and information bias [59]. Regardless, critical
issues for bias prevention are different between design types. In cross-sectional studies, three points
were mainly evaluated: sample randomization; reliability and objectivity of variables assessment; as
well as definition of group if comparisons were made. In case–control studies, objectivity and reliability
of evaluations of subjects was also taken into account. For this study type, category definitions and
exposures evaluation method also were included. Lastly, in cohort studies, exposure and status
definition, measurement, differences in duration, reliability, and objectivity of outcome assessment
were considered, as well as the presence of differences in intensity of medical surveillance, loss of
follow-up, and missing data treatment. In addition, possible differences in outcomes or exposure
to risk factors between subjects who drop out and those who stay in the study were taken into
account. Inclusion criteria and/or sources of data or individuals’ background were considered for
the establishment of sample external validity and population set represented. Additionally, grouping
criteria in data analysis were taken into account, when they were presented, especially if they were
selected post hoc from alternative options.
On the other hand, intervention trials were assessed according to Cochrane guidelines, which take
into account five type of bias: selection, performance, detection, attrition, and reporting bias [60]. Based
in its recommendations, the following domains were evaluated: sequence generation (randomization),
allocation concealment, blinding of participants, operators and/or examiners, incomplete outcome
data, and selective reporting. With regard to the results of this assessment, degree of risk (high, low, or
unclear) was established for each type of bias, as well as its possible magnitude and direction. The risk
of bias and its possible effects were summarized for each outcome within each study. Finally, it was
summarized for the review as a whole, where it was possible.
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Abbreviations
BOP bleeding on probing
CAL clinical attachment loss
CI confidence interval
CPI Community Periodontal Index
DHA docosahexaenoic acid
DM diabetes mellitus
EPA eicosapentanoic acid
FFQ food frequency questionnaire
GCF gingivocrevicular fluid
GI Gingival Index
GLA γ-linoleic acid
hsCRP high sensitivity C-reactive protein
IRR incidence rate ratio
LDL low density lipoprotein
Mesh Medical Subjects Headings
MGI Modified Gingival Index
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MMP-8 matrix metalloproteinase-8
NHANES National Health and Nutrition Survey
OR odds ratio
PI Plaque Index
PPD Periodontal probing depth
PUFA polyunsaturated fatty acid
RANKL receptor activator of nuclear factor κB ligand
RCT randomized-controlled trial
RR relative risk
SBI Sulcus Bleeding Index
SFA saturated fatty acids
SRP scaling and root planning
TLR-4 toll-like receptor 4
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